Search - tctmd.com

Displaying 781 - 800 of 892

Sort: Relevancy | Date

News Daily News

Catheter-Based Measurement of Plaque Lipid Predicts Future Events

December 10, 2014

News Daily News

Vorapaxar可以防范意外缺血性卒中、支架内血栓形成

December 04, 2014

News Daily News

Vorapaxar podría Proteger frente a ACV Isquémicos Incidentales y Trombosis del Stent

December 04, 2014

News Daily News

Vorapaxar May Protect Against Incident Ischemic Stroke, Stent Thrombosis

December 04, 2014

News Conference News AHA 2014

Biodegradable-Polymer DES Perform Well But Appear No Safer than Their Durable-Polymer Counterparts

November 18, 2014

News Daily News

Majority of Deaths Over Time in STEMI Patients Not Cardiovascular Related

November 17, 2014

News Conference News AHA 2014

Vorapaxar Safe in NSTE-ACS But Bleeding Risk Merits 6-Month Delay Before Noncardiac Surgery

Yael L. Maxwell

November 16, 2014

News Conference News AHA 2014

Ezetimibe Proves Clinical Benefit on Top of Statin Therapy

November 16, 2014

News Conference News AHA 2014

Extending Clopidogrel Past 1 Year Improves Outcomes in DES, But Not BMS Patients

Yael L. Maxwell

November 16, 2014

News Conference News AHA 2014

DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation

Yael L. Maxwell

November 16, 2014

News Conference News AHA 2014

Long-Term Better than Short-Term Prasugrel After PES Stenting

November 15, 2014

No: Vorapaxar Is Effective, but Prasugrel and Ticagrelor are Preferred!

Presentation TCT 2014

No: Vorapaxar Is Effective, but Prasugrel and Ticagrelor are Preferred!

Presenter: Dirk Sibbing

September 14, 2014

Yes: TRA-2P Has Proven it!

Presentation TCT 2014

Yes: TRA-2P Has Proven it!

Presenter: David J. Moliterno

September 14, 2014

NO: Cangrelor Is No Champion Next to the Appropriate Use of Potent Oral Antiplatelet Agents!

Presentation TCT 2014

NO: Cangrelor Is No Champion Next to the Appropriate Use of Potent Oral Antiplatelet Agents!

Presenter: Dimitrios Alexopoulos

September 14, 2014

YES: CHAMPION PHOENIX was Convincing!

Presentation TCT 2014

YES: CHAMPION PHOENIX was Convincing!

Presenter: Deepak L. Bhatt

September 14, 2014

Yes: WOEST Definititely Proves Safety and Likely Efficacy as Well!

Presentation TCT 2014

Yes: WOEST Definititely Proves Safety and Likely Efficacy as Well!

Presenter: Harvey D. White

September 14, 2014

News Industry News

Amgen Announces Positive Top-Line Results From Phase 3 YUKAWA-2 Trial Of Evolocumab In Combination With Statins In Japanese Patients With High Cardiovascular Risk And High Cholesterol

August 28, 2014

News Daily News

Majority of US Patients Still Discharged on High-Dose Aspirin After Acute MI

August 20, 2014

News Daily News

Cardiac Troponin T Threshold Predicts Mortality After PCI

August 20, 2014

News Daily News

Post-AMI Ischemic Stroke Rates Down, Hemorrhagic Stroke Stable Since 1999

July 03, 2014

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.